$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
培米替尼的使用方法和副作用是什么?
2025-10-19 11:44:20
Check Details
培米替尼pemigatinib是治疗胆管癌的靶向药
2025-10-19 11:44:20
Check Details
第二款胆管癌靶向药物—英菲格拉替尼获批上市
2025-10-19 11:44:20
Check Details
英菲格拉替尼的用法用量是怎样的?有什么副作用?
2025-10-19 11:44:20
Check Details
先行先试!近日,胆管癌新药英菲格拉替尼在海南开出首张处方
2025-10-19 11:44:20
Check Details
英菲格拉替尼显示出治疗FGFR2改变的晚期胆管癌的潜力
2025-10-19 11:44:20
Check Details
英菲格拉替尼现在在上海能够买到吗?
2025-10-19 11:44:20
Check Details
英菲格拉替尼Truseltiq治疗胆管癌效果显著
2025-10-19 11:44:20
Check Details
佩米替尼片治疗胆管癌疗效如何?治疗时要注意什么
2025-10-19 11:44:20
Check Details
全球首个!美国FDA批准艾伏尼布用于治疗IDH1突变胆管癌
2025-10-19 11:44:20
Check Details
胆管癌靶向药佩米替尼(达伯坦)可显著提高疾病控制率
2025-10-19 11:44:20
Check Details
英菲格拉替尼能与食物同服吗?使用时要注意什么
2025-10-19 11:44:20
Check Details
1
2
...
29
30
31
32
33
34
35
...
4154
4155
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
FDA Accelerates Approval of Zongertinib: Precision Medicine Advancement for HER2-Mutated NSCLC
2
Sotorasib (Lumakras®): The First KRAS Inhibitor Revolutionizing Non-Small Cell Lung Cancer Treatment
3
LONSURF® (Trifluridine/Tipiracil): Unveiling the Global R&D and Supply Chain Behind the Oral Chemotherapy
4
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
5
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
6
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
7
Adagrasib Medication Management Guide for Special Populations
8
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
9
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
10
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
11
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
12
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers